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A B S T R A C T
Background: The hippocampus has recently been identiﬁed to play a key role in the pathophysiology of adult
obsessive-compulsive disorder (OCD). Surprisingly, there is only limited evidence regarding the potential re-
lationships with symptom dimensions. Due to the heterogeneity of symptoms in OCD, we aimed at further
examining, whether hippocampal volume diﬀerences might be related to symptom proﬁles instead of single
symptom dimensions.
Methods: In order to ﬁnd out more about the potential association between clinical symptom proﬁles and al-
terations in hippocampal volume we categorized a large sample of OCD patients (N= 66) into distinct symptom
proﬁle groups using K-means clustering. In addition, hippocampal volumes of the diﬀerent symptom proﬁle
groups were compared with hippocampal volumes in a sample of 66 healthy controls.
Results: We found signiﬁcant diﬀerences in hippocampal volume between the diﬀerent symptom proﬁle groups
which remained signiﬁcant after correcting for age, sex, total intracranial volume, OCI-total score, depression,
medication, disease duration and scanner. The patient group characterized by overall lower symptom scores and
without high symptom severity in any speciﬁc domain showed the highest hippocampal volume. Finally, the
comparison with healthy controls demonstrated signiﬁcantly lower hippocampal volumes in those patients
whose symptom proﬁle was characterized by a high severity of ordering and checking symptoms.
Conclusions: Present results provide further conﬁrmation for alterations in hippocampus structure in OCD and
suggest that symptom proﬁles which take into account the multi-symptomatic character of the disorder should
be given greater attention in this context.
1. Introduction
Despite increasing evidence for structural brain alterations in ob-
sessive-compulsive disorder (OCD) the overall picture has to be con-
sidered as rather heterogeneous with ﬁndings reporting both increases
and decreases in gray matter volume, thickness, surface area or gyr-
iﬁcation (Fan et al., 2013; Kuhn et al., 2013; Nakamae et al., 2012;
Piras et al., 2015; Rus et al., 2016; Shaw et al., 2015; Shin et al., 2007;
Venkatasubramanian et al., 2012; Wobrock et al., 2010). In an attempt
to reduce overall result heterogeneity and to ﬁlter out the most
meaningful alterations, an increasing number of meta-analyses pooling
data from multiple OCD sites worldwide are emerging in the OCD re-
search community (Boedhoe et al., 2017; De Wit et al., 2014; Fouche
et al., 2017). The ENIGMA consortium analysis constitutes the largest
meta-analysis on structural alterations in OCD to date. Employing a
coordinated and standardized analysis approach, meta- and mega-
analysis of data from 1830 OCD patients (N= 335 children, N= 1495
adults) and 1759 controls was conducted to identify alterations in
subcortical brain volumes in OCD patients compared to healthy controls
(Boedhoe et al., 2017). As one of the main ﬁndings the analysis revealed
the adult patient sample to have signiﬁcantly increased pallidum and
signiﬁcantly smaller hippocampus volumes compared to healthy con-
trols. The pallidum is regarded as one of the core regions within the
frequently discussed cortico-striato-thalamo-cortical (CSTC) circuit. A
dysbalance within this circuit is assumed to represent a central psy-
chopathological mechanism underlying obsessions and compulsions in
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OCD. In contrast, the hippocampus has not been the focus of OCD
psychopathophysiology up to now. Its volume, however, is frequently
found to be decreased in other psychiatric disorders such as depression
(Frodl and O'Keane, 2013; Malykhin and Coupland, 2015) and PTSD
(Ahmed-Leitao et al., 2016; O'Doherty et al., 2015). One potential
mechanism underlying volumetric changes in the hippocampus seems
to be uncontrollable stress (i.e., stress perceived as distress) which is
one of the main characteristics of many psychiatric disorders such as
PTSD. Distress has been demonstrated to change neuronal morphology,
suppress neuronal proliferation, and reduce hippocampal volume (Kim
et al., 2015). According to ICD-10, OCD is classiﬁed as a stress-related
disorder and patients with OCD tend to report high levels of stress and
anxiety independent of their speciﬁc symptoms or symptom proﬁles
(Stein et al., 2010). Therefore, there is strong reason to assume that
hippocampal volume diﬀerences may be clinically relevant in OCD as
well. Of note, the ENIGMA meta-analysis identiﬁed hippocampal vo-
lume diﬀerences to be larger in medicated patients, however, no re-
lationship with symptoms was found. The ENIGMA study related vo-
lume diﬀerences to speciﬁc symptoms as assessed by the Y-BOCS
checklist. However, it should be noted that the majority of all OCD
patients are multi-symptomatic and the individual symptom proﬁles of
OCD patients are heterogeneous to the extent that two patients may
display diﬀerent overlapping or even non-overlapping symptom pat-
terns (Mataix-Cols et al., 2005). Hence, instead of correlating outcome
measures with speciﬁc symptoms one at a time, it may be reasonable to
adopt an approach that accounts for possible interrelations of diﬀerent
symptom dimensions in patients. The fact that Boedhoe et al. (2017)
found no signiﬁcant correlations between symptom dimensions and
hippocampus volumes is striking given the clear involvement of volume
diﬀerences in patients found in their study. One possible explanation
might be that symptom dimensions were related to structural altera-
tions while controlling for the eﬀects of other symptom dimensions,
therefore eﬀectively treating each symptom in isolation. To ﬁnd out
more about the clinical relevance of the recently reported diﬀerences in
hippocampal structure, the present study employs a cluster analysis
approach on dimensional symptoms to reach a diﬀerentiation into
distinct symptom composition proﬁles, comparing hippocampal vo-
lumes between the diﬀerent symptom proﬁle groups. Thus, we aimed at
exploring whether taking into account the interrelation between dif-
ferent symptoms, i.e., patients´ symptom composition proﬁle, would be
a valuable approach to relate structural alterations to clinically relevant
features. We assumed that if the hippocampus would indeed be dif-
ferentially aﬀected in dependence on speciﬁc symptom composition
proﬁles volume diﬀerences should be related to diﬀerent symptom
proﬁles. If hippocampus volumes would not be related to symptom
proﬁles, this would rather speak in favor of a clinically unspeciﬁc
hippocampal involvement in the disease.
2. Methods and materials
2.1. Participants
Data from two samples were combined. Sample one (S1) comprised
n= 42 patients and n= 46 healthy controls and sample two (S2)
comprised n= 24 patients and n= 20 healthy controls resulting in a
total size of n= 66 patients with OCD as the primary diagnosis ac-
cording to DSM-IV criteria and n= 66 healthy controls (see Table 1 for
demographic and clinical details). Patients and controls were matched
for sex and age in both samples. All patients were recruited from the
Windach Institute and Hospital of Neurobehavioural Research and
Therapy, Germany, and diagnoses were made by an experienced psy-
chiatrist. Exclusion criteria for all participants were a history of clini-
cally important head injuries, seizures or neurological diseases. At time
of the study, n= 48 patients were drug-naive or medication free for at
least 3 weeks and n= 30 patients had one or more comorbid diagnoses.
To assess clinical severity of obsessive-compulsive symptoms, patients
were administered the self-rated version of the Yale-Brown Obsessive-
Compulsive Scale (Y-BOCS) (Goodman et al., 1989; Hand and Büttner-
Westphal, 1991). The Obsession-Compulsion Inventory revisited (OCI-
R) (Foa et al., 2002; Gonner et al., 2008) was administered to more
speciﬁcally assess diﬀerent symptom dimensions. Additionally, de-
pressive symptoms were evaluated based on the Beck Depression In-
ventory (BDI-II) (Beck et al., 1996; Hautzinger et al., 2009) in patients
of sample S1 and the Hamilton Depression Scale (HAM-D) (Hamilton,
1960) in patients of sample S2. The study was approved by the local
Ethics Committee of the Klinikum rechts der Isar, München and was
conducted in accordance with the Declaration of Helsinki.
2.2. Image acquisition
Magnetic resonance imaging was conducted on a 3T Philips Ingenia
(Philips Healthcare, Best, The Netherlands) using a 12-channel (SENSE)
head coil. For sample S1, structural imaging consisted of a T1-weighted
3D MPRAGE sequence with an isotropic resolution of 1 mm (170 slices,
sagittal orientation, 240 × 240 matrix, TR = 9 ms, TE = 4 ms, ﬂip
angle = 8°) while for sample S2, imaging consisted of a T1-weighted 3D
MPRAGE sequence with a resolution of 0.7 × 0.75 × 0.7 mm (230
slices, sagittal orientation, 368 × 340 matrix, TR = 11 ms,
TE = 5.1 ms, ﬂip angle = 8°). Prior to analysis the 24 submillimeter
data sets of sample S2 were downsampled in order for all images to
have a consistent resolution of 1 mm isotropic.
Table 1
Demographic and clinical sample characteristics.
Characteristics OCD HC
n n
Mean ± SD Mean ± SD
Sample size 66 66
Female 46 (69.7%) 46 (69.7%)
Age (years) 32.4 ± 10.5 31.6 ± 10.3‡
Disease duration 16.0 ± 10.8
Y-BOCS total 21.0 ± 6.2
Obsession 11.0 ± 3.6
Compulsions 9.9 ± 3.9
OCI-R total 25.4 ± 10.0
Hoarding 2.3 ± 2.6
Checking 5.5 ± 3.6
Ordering 3.9 ± 3.8
Neutralizing 2.2 ± 2.9
Washing 4.8 ± 3.9
Obsessing 6.8 ± 3.6
BDI (S1) 18.0 ± 11.5
HAM-D (S2) 12.6 ± 4.9
Comorbidities 30 (45.5%)
Depression 23
Anxiety disorder 10
Personality disorder 4
Eating disorder 2
ADHD 2
Medication 48 (72.7%)
SSRI 35
SSRNI 6
Neuroleptic 5
TCA 3
Methylphenidate 1
Benzodiazepine 1
NDRI 1
NaSSA 1
Note that multiple comorbid diagnoses as well as diﬀerent medication types can be
present in a single patient; abbreviations for medication: NaSSA, noradrenergic and
speciﬁc serotonergic antidepressant; NDRI, norepinephrine-dopamine reuptake inhibitor;
SSNRI, selective serotonin-norepinephrine reuptake inhibitor; SSRI, selective serotonin
reuptake inhibitor; TCA, tricyclic antidepressant.
‡ Two-sample t-test (t(130) = 0.442, p= 0.659).
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2.3. Image processing
Based on these T1-weighted images, cortical and subcortical struc-
tures were initially segmented and labeled using Freesurfer (Version
6.0, http://surfer.nmr.mgh.harvard.edu/) (Dale et al., 1999; Fischl
et al., 2002; Fischl et al., 1999). Processing included automatic seg-
mentation into gray and white matter tissue compartments followed by
parcellation of the gray matter mask into distinct brain regions and
reconstruction of brain surfaces. These results were subsequently used
to initialize the labeling of hippocampi using the recently released
hippocampal subﬁeld segmentation algorithm implemented in the
Freesurfer package. Compared to previous versions, the labeling rests
on an atlas which was built based on ex vivo MRI data of postmortem
brain tissue acquired at 7T with sub-millimeter resolution and results
have been shown to be in better agreement with histological studies
(Iglesias et al., 2015). Hippocampus segmentations were visually in-
spected and volumes were quantitatively checked for outliers.
2.4. Symptom composition analysis (SCA)
In order to partition the patients according to their symptom com-
position, all OCI-R items were entered into a K-means cluster analysis in
SPSS (IBM Corp. Released 2016. IBM SPSS Statistics for Windows,
Version 24.0. Armonk, NY: IBM Corp). This type of analysis allows to
derive subgroups whose members are characterized by being rather
similar in symptom composition within each subgroup while being as
diﬀerent as possible in symptom composition to members of other
subgroups. The number of clusters (k) to be extracted was predeﬁned to
k = 3. This number was chosen in order to extract a number of clusters
that allows for suﬃcient diﬀerentiability of patients while preserving a
relatively large number of subjects per clusters (see Supplementary
Fig. 1 for further details).
2.5. Statistical analysis
Demographic and clinical characteristics of subjects forming the
three diﬀerent clusters were compared using one-way ANOVAs with the
respective demographic or clinical variable as dependent variable and
cluster membership as factor with three factor levels. In line with
Boedhoe et al. (2017) hippocampus volumes of the left and right
hemisphere were averaged to yield a single hippocampus volume for
each subject. For patients only, an ANCOVA model was ﬁt to assess
cluster-related diﬀerences in hippocampus volume while controlling for
the following covariates: age, sex, total intracranial volume, OCI-total
score, depression, medication, disease duration, and scanner. Control-
ling for OCI-total scores allows the assessment of potential eﬀects of
cluster membership irrespective of cluster-speciﬁc diﬀerences in global
OCI symptom severity. Medication was entered as a dichotomous
variable indicating whether patients were medication naïve or medi-
cation free for at least three weeks prior to scanning. HAM-D and BDI
scores were transformed into a dichotomous variable and used as a
proxy to indicate the absence or presence of clinically relevant de-
pressive symptoms. HAM-D scores≥ 9 and BDI scores≥ 13 were
considered to indicate the presence of relevant depressive symptoms
Fig. 1. Symptom proﬁle composition and hippocampal volumes. Symptom composition analysis (A): Mean scores of each OCI-R item according to cluster membership, grouped by
symptom dimensions. Numbers in parentheses indicate the number of each item in the questionnaire. Within patients analysis (B): Marginal means ± standard error. There was a
signiﬁcant main eﬀect of cluster membership on global hippocampal volume while controlling for age, sex, total intracranial volume, total OCI-R score, clinically relevant depression,
medication, disease duration and scanner (F(2,55) = 3.301, p= 0.044). Between groups analysis (C): Marginal means ± standard error. There was a signiﬁcant main eﬀect of cluster on
global hippocampal volume while controlling for age, sex, and total intracranial volume (F(3,125) = 4.752, p= 0.004).
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according to the German National Disease Management Guideline De-
pression (DGPPN and KBV, 2015). In a second analysis, potential
cluster-related diﬀerences in hippocampus volumes between patients
and healthy controls were assessed. To this end, an ANCOVA model was
ﬁt treating all healthy controls as belonging to one synthetic cluster of
their own resulting in the factor cluster with four levels. Additionally,
the analysis was controlled for the following covariates: age, sex, and
total intracranial volume.
3. Results
3.1. Symptom composition analysis (SCA)
The mean scores of each OCI-R item according to cluster member-
ship are depicted in Fig. 1A. Items are grouped together according to
OCI symptom scales. ANOVA analyses revealed a signiﬁcant main eﬀect
of cluster on OCI total score (F(2,63) = 34.924, p < 0.001, corrected).
Information regarding demographic characteristics and statistical dif-
ferences between each patient cluster are depicted in Table 2.
3.2. Hippocampus volume
3.2.1. Within patients analysis
There was a signiﬁcant main eﬀect of cluster on global hippocampus
volume while controlling for age, sex, total intracranial volume, total
OCI-R score, clinically relevant depression, medication, disease dura-
tion, and scanner (F(2,55) = 3.301, p= 0.044, η2 = 0.057).
Additionally, there was a signiﬁcant main eﬀect of sex (F(1,55)
= 6.429, p= 0.014, η2 = 0.055), total intracranial volume (F(1,55)
= 7.291, p= 0.009, η2 = 0.063), presence or absence of clinically
relevant depression (F(1,55) = 5.613, p= 0.021, η2 = 0.048) and
scanner (F(1,55) = 5.354, p= 0.024, η2 = 0.017) (see Fig. 1B as well
as Table 3). Post-hoc tests indicated that hippocampus volume was
signiﬁcantly diﬀerent between cluster 2 and 3 (p= 0.020, 95% CI
[−562.77, −49.47]) while there was a trend signiﬁcant diﬀerence
between cluster 1 and 3 (p= 0.056, 95% CI [−432.59, 5.75]) and no
signiﬁcant diﬀerence between clusters 1 and 2 (p= 0.456, 95% CI
[−154.82, 340.21]). For exploratory analyses of hippocampus subﬁeld
volumes see Supplementary Table I.
3.2.2. Between groups analysis
There was a signiﬁcant main eﬀect of cluster on global hippocampus
volume while controlling for age, sex, total intracranial volume and
scanner (F(3,125) = 4.752, p= 0.004, η2 = 0.071). Additionally,
there was a signiﬁcant main eﬀect of sex (F(1,125) = 10.914
p= 0.001, η2 = 0.081), total intracranial volume (F(1,125) = 17.758
p < 0.001, η2 = 0.088) and scanner (F(1,125) = 6.797 p= 0.010,
η2 = 0.034) (see Fig. 1C as well as Table 4). Post-hoc tests were con-
ducted to compare each patient cluster with healthy controls (c1 vs. HC,
c2 vs. HC, c3 vs. HC). For this comparison alpha was Bonferroni-cor-
rected to be α= 0.05/3 or α= 0.017. Cluster 2 was found to be sig-
niﬁcantly diﬀerent from HC (p= 0.012, 95% CI [−297.39,−37.47]).
Diﬀerences between cluster 3 and healthy controls (p= 0.063, 95% CI
[−255.23, 6.75]) as well as between cluster 1 and HC were not sig-
niﬁcant (p= 0.366, 95% CI [−82.68, 222.46]).
Table 2
Demographic and clinical sample characteristics in the three patient groups.
Characteristics Cluster 1 Cluster 2 Cluster 3 F-statistic p-Value
Mean ± SD Mean ± SD Mean ± SD
n(%) n(%) n(%)
OCI total 23.47 ± 8.65 34.12 ± 6.46 17.67 ± 6.13 34.924 < 0.001⁎
Age 31.38 ± 11.20 33.63 ± 11.06 31.90 ± 9.72 0.266 0.767
Disease duration 12.88 ± 6.61 18.92 ± 13.59 15.04 ± 9.58 1.742 0.184
Male 1 (5.9%) 9 (36.0%) 10 (41.7%) 3.531 0.035
Depression 9 (52.9%) 21 (84%) 17 (70.8%) 2.451 0.094
Medication 15 (88.2%) 20 (80.0%) 14 (58.3%) 2.779 0.070
⁎ p < 0.05, Bonferroni-corrected for the total number of ANOVAs computed.
Table 3
ANCOVA model details for within patients analysis.
Sum of squares (Typ III) df Mean squares F Signiﬁcance η2 Partial η2
Corrected model 5,342,274.95 10 534,227.50 6.107 < 0.001 0.526
Constant term 3,484,000.10 1 3,484,000.10 39.829 < 0.001 0.420
Cluster 577,495.26 2 288,747.63 3.301 0.044⁎ 0.057 0.107
Age 27,210.95 1 27,210.95 0.311 0.579 0.003 0.006
Sex 562,325.53 1 562,325.53 6.429 0.014⁎ 0.055 0.105
ICV 637,788.24 1 637,788.24 7.291 0.009⁎ 0.063 0.117
OCI total 11,522.83 1 11,522.83 0.132 0.718 0.001 0.002
Depression 490,991.26 1 490,991.26 5.613 0.021⁎ 0.048 0.093
Medication 16,746.94 1 16,746.94 0.191 0.663 0.002 0.003
Disease duration 66,142.75 1 66,142.75 0.756 0.388 0.007 0.014
Scanner 168,298.30 1 168,298.30 5.354 0.024⁎ 0.017 0.089
Error 4,811,035.05 55 87,473.37
Total 812,213,858.70 66
Corrected total variation 10,153,310.00 65
⁎ =p < 0.05;
ANCOVA model formulation:
hippovol=2697.20−213.42∗clust1−306.12∗clust2−3.18∗age+275.47∗sex+0.001∗ICV+2.09∗OCItotal−204.19∗depression+38.93∗medication+5.14∗disease duration+231.78∗scanner.
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4. Discussion
To ﬁnd out more about the clinical relevance of hippocampal vo-
lume changes in OCD, in the present study we categorized a large
sample of OCD patients into three distinct symptom proﬁles and com-
pared alterations in hippocampal volume between the resulting groups.
We further compared the resulting clusters with healthy participants.
With this procedure we aimed at further elucidating the clinical sig-
niﬁcance of hippocampal volume alterations by better accounting for
the clinical heterogeneity of the disorder. The cluster analysis showed
that the relatively large patient sample could be subdivided most ade-
quately into three symptom proﬁle groups. Common to all clusters was
the moderate to high level of obsessing symptoms. This feature thus
does not seem be the major driving factor regarding hippocampus vo-
lume diﬀerences. Similar, but less pronounced are the dimensions
neutralizing and hoarding. Here, the overall symptom strength is low to
moderate with slight diﬀerences between clusters. The main diﬀerences
between clusters could be found for the dimensions washing, ordering,
and checking. Here cluster 1 revealed by far the highest washing scores
while being on par with cluster 3 on ordering and checking symptoms.
Cluster 2 revealed intermediate washing symptoms while scoring the
highest on ordering as well as checking symptoms. On a side note,
cluster 1, characterized by the highest washing symptoms, contained
only a single male patient and 16 female patients. This is in line with
earlier studies reporting washing symptoms predominantly in female
patients (Labad et al., 2008; Mathis et al., 2011; Torresan et al., 2013).
As a main ﬁnding the present analysis demonstrated that hippocampus
volume diﬀered signiﬁcantly between the three groups with post-hoc
tests indicating that cluster 2 had signiﬁcantly smaller hippocampal
volumes than cluster 3. Importantly, this result was corrected for the
inﬂuence of overall symptom severity (i.e., OCI-R total score) which
indicates that the respective symptom proﬁles account for variation in
hippocampal volume independent of overall symptom severity. Hence,
present ﬁndings clearly demonstrate that the classiﬁcation into dif-
ferent OCD symptom proﬁles – an approach which has been re-
commended already years ago (Mataix-Cols et al., 2005) – signiﬁcantly
accounts for variation in hippocampal volume reduction. Additionally,
there was a diﬀerence between hippocampal volumes when including a
group of healthy subjects, with post-hoc tests indicating signiﬁcant
diﬀerences between cluster 2 and healthy controls. Present ﬁndings
moreover extend recent results from the currently largest meta-analysis
on structural alterations in OCD (i.e., the ENIGMA consortium meta-
analysis) which revealed signiﬁcantly smaller hippocampal volumes in
adult OCD patients compared to healthy controls (Boedhoe et al.,
2017). The meta-analysis showed the eﬀect to be stronger in medicated
patients compared to controls but not signiﬁcantly related to clinical
symptoms. However, unlike in the present study, in this meta-analysis
symptom spectra or the interrelation between diﬀerent symptoms was
not taken into account but symptoms were assessed independently for
each Y-BOCS checklist symptom dimension. Present ﬁndings not only
corroborate the clinical relevance of hippocampal volume alterations in
OCD as reported before (Honda et al., 2017) but strongly suggest that
the interrelation of symptom dimensions should be taken into account
in this regard. As also shown in Fig. 1A, it seems that a high severity of
mainly ordering and checking symptoms (i.e., cluster 2) may be pre-
dominantly indicative of a reduction in hippocampus volume. The
hippocampus is a highly stress-sensitive structure (Kim et al., 2015) and
is often found to be reduced in volume in other stress-related disorders
such as depression (MacQueen, 2009) and PTSD (Ahmed-Leitao et al.,
2016). Hence, there is reason to assume that the association between a
high level of predominantly ordering/checking (cluster 2) and - to a
somewhat lesser extent predominantly washing (cluster 1) symptoms -
and reduced hippocampal volume may be mediated via stress and
stress-related physiological processes going along with these symptom
proﬁles and their associated behavior. In this context it is interesting to
note that the association remained signiﬁcant even after correcting for
the comorbidity of depression. Moreover, the association between
symptom proﬁle and hippocampal volume also remained signiﬁcant
after correcting for the inﬂuence of disease duration. In this case, dis-
ease duration did not have a signiﬁcant eﬀect on hippocampal volume.
This ﬁnding seems to contradict the above formulated assumption that
stress going along with the disorder may play a relevant role in this
context. However, ﬁndings from meta-analyses on hippocampal vo-
lumes in depression produced relatively conﬂicting results and sug-
gested that disease duration may be a signiﬁcant inﬂuencing factor
mainly in elderly patients (Eker and Gonul, 2010) (i.e., hippocampal
degenerative processes due to disorder-related stress may become
manifest predominantly in elderly patients who had been suﬀering from
depression for various years). Of note, the average disease duration
between clusters was not signiﬁcantly diﬀerent, i.e., overall eﬀects of
disease duration had no signiﬁcant inﬂuence on this type of analysis.
This ﬁnding does therefore not rule out the possibility of disease
duration related eﬀects on hippocampal volumes in general. Apart from
the above mentioned meta-analysis (Boedhoe et al., 2017) which
showed a signiﬁcantly decreased hippocampal volume in patients with
OCD, a limited amount of previous studies already reported alterations
in hippocampus structure and neurochemistry in patients with OCD.
For instance, Honda et al. (2017) found a decreased hippocampal vo-
lume in OCD patients employing voxel-based analyses and Hong et al.
(2007) observed a bilateral hippocampal shape deformity in OCD pa-
tients compared to healthy controls when performing a shape analysis
of the hippocampus. Regarding hippocampal neurochemistry lower
hippocampal ratio of N-acetyl-L-aspartate/choline (NAA/CHO) which is
considered to indicate loss of neurons and axons has been reported in
patients with OCD (Atmaca et al., 2009). Interestingly, follow-up stu-
dies found these alterations to partly normalize by eﬀective treatment
and clinical improvement (Atmaca et al., 2015). Hence, our ﬁnding that
patients with a symptom proﬁle characterized by a high level of
Table 4
ANCOVA model details for between groups analysis.
Sum of squares (Typ III) df Mean squares F Signiﬁcance η2 Partial η2
Corrected model 5,882,377.33 7 840,339.618 11.003 < 0.001 0.383
Constant term 9,327,886.03 1 9,327,886.03 122.130 < 0.001 0.496
Cluster 1,088,735.90 3 362,911.97 4.752 0.004⁎ 0.071 0.103
Age 6681.42 1 6681.42 0.087 0.768 < 0.001 0.001
Sex 833,600.24 1 833,600.24 10.914 0.001⁎ 0.054 0.081
ICV 1,356,312.68 1 1,356,312.68 17.758 < 0.001⁎ 0.088 0.125
scanner 519,145.23 1 519,145.23 6.797 0.010⁎ 0.034 0.052
Error 9,470,732.19 124 76,376.87
Total 1,647,001,109.00 132
Corrected total variation 15,353,109.51 131
⁎ =p < 0.05;
ANCOVA model formulation:
hippovol=2534.54−69.89∗clust1−167.43∗clust2+124.29∗clust3+0.70∗age+200.56∗sex+0.001∗ICV+159.60∗scanner.
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predominantly checking/ordering symptoms (cluster 2) showed
stronger hippocampal volume diﬀerences compared to patients without
a high severity in any speciﬁc domain as well as an overall lower
symptom severity (cluster 3) complements these results. Taken to-
gether, present and earlier ﬁndings suggest that alterations in hippo-
campal volume in terms of neuroplasticity or partial reversal of tissue
loss may be an indicator of treatment-related clinical improvement
whereas hippocampal volume in terms of volumetric loss may represent
a state marker of disease severity if assessed dimensionally according to
speciﬁc symptom spectra or the interrelation between speciﬁc symptom
dimensions. Longitudinal study designs might further elucidate an in-
teraction between attenuation of strength in symptom proﬁles due to
therapy and associated hippocampus volume changes.
5. Limitations
In opposition to the results of the currently largest meta-analysis
(Boedhoe et al., 2017) which found that hippocampal volume reduc-
tions were stronger in medicated patients compared to controls we only
found a trend signiﬁcant inﬂuence of medication on volumes. These
partly conﬂicting ﬁndings may have mainly statistical reasons as it must
be assumed that the meta-analysis based on a sample of 1495 adult
OCD patients had considerably larger detection power than the present
study. The deﬁnition of clinically relevant depression was based on two
diﬀerent questionnaires (self-rated and clinician-rated) resulting from
the aggregation of two diﬀerent samples. Therefore, the factor de-
pression should be assessed in further studies using the same ques-
tionnaires for the deﬁnition of cut-oﬀs.
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